BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Beuckmann CT, Sinton CM, Williams SC, Richardson JA, Hammer RE, Sakurai T, Yanagisawa M. Expression of a poly-glutamine-ataxin-3 transgene in orexin neurons induces narcolepsy-cataplexy in the rat. J Neurosci 2004;24:4469-77. [PMID: 15128861 DOI: 10.1523/JNEUROSCI.5560-03.2004] [Cited by in Crossref: 127] [Cited by in F6Publishing: 57] [Article Influence: 7.1] [Reference Citation Analysis]
Number Citing Articles
1 Winrow CJ, Renger JJ. Discovery and development of orexin receptor antagonists as therapeutics for insomnia. Br J Pharmacol 2014;171:283-93. [PMID: 23731216 DOI: 10.1111/bph.12261] [Cited by in Crossref: 86] [Cited by in F6Publishing: 88] [Article Influence: 10.8] [Reference Citation Analysis]
2 Tisdale RK, Yamanaka A, Kilduff TS. Animal models of narcolepsy and the hypocretin/orexin system: Past, present, and future. Sleep 2021;44:zsaa278. [PMID: 33313880 DOI: 10.1093/sleep/zsaa278] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Kohlmeier KA, Watanabe S, Tyler CJ, Burlet S, Leonard CS. Dual orexin actions on dorsal raphe and laterodorsal tegmentum neurons: noisy cation current activation and selective enhancement of Ca2+ transients mediated by L-type calcium channels. J Neurophysiol 2008;100:2265-81. [PMID: 18667550 DOI: 10.1152/jn.01388.2007] [Cited by in Crossref: 59] [Cited by in F6Publishing: 65] [Article Influence: 4.2] [Reference Citation Analysis]
4 Mieda M, Williams SC, Sinton CM, Richardson JA, Sakurai T, Yanagisawa M. Orexin neurons function in an efferent pathway of a food-entrainable circadian oscillator in eliciting food-anticipatory activity and wakefulness. J Neurosci 2004;24:10493-501. [PMID: 15548664 DOI: 10.1523/JNEUROSCI.3171-04.2004] [Cited by in Crossref: 151] [Cited by in F6Publishing: 63] [Article Influence: 8.9] [Reference Citation Analysis]
5 Kaur S, Thankachan S, Begum S, Liu M, Blanco-Centurion C, Shiromani PJ. Hypocretin-2 saporin lesions of the ventrolateral periaquaductal gray (vlPAG) increase REM sleep in hypocretin knockout mice. PLoS One 2009;4:e6346. [PMID: 19623260 DOI: 10.1371/journal.pone.0006346] [Cited by in Crossref: 44] [Cited by in F6Publishing: 46] [Article Influence: 3.4] [Reference Citation Analysis]
6 Stettner GM, Kubin L. Antagonism of orexin receptors in the posterior hypothalamus reduces hypoglossal and cardiorespiratory excitation from the perifornical hypothalamus. J Appl Physiol (1985) 2013;114:119-30. [PMID: 23104701 DOI: 10.1152/japplphysiol.00965.2012] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
7 Bergman P, Adori C, Vas S, Kai-Larsen Y, Sarkanen T, Cederlund A, Agerberth B, Julkunen I, Horvath B, Kostyalik D, Kalmár L, Bagdy G, Huutoniemi A, Partinen M, Hökfelt T. Narcolepsy patients have antibodies that stain distinct cell populations in rat brain and influence sleep patterns. Proc Natl Acad Sci U S A 2014;111:E3735-44. [PMID: 25136085 DOI: 10.1073/pnas.1412189111] [Cited by in Crossref: 59] [Cited by in F6Publishing: 54] [Article Influence: 7.4] [Reference Citation Analysis]
8 Schwimmer H, Stauss HM, Abboud F, Nishino S, Mignot E, Zeitzer JM. Effects of sleep on the cardiovascular and thermoregulatory systems: a possible role for hypocretins. J Appl Physiol (1985) 2010;109:1053-63. [PMID: 20705949 DOI: 10.1152/japplphysiol.00516.2010] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 3.1] [Reference Citation Analysis]
9 Deboer T. Technologies of sleep research. Cell Mol Life Sci 2007;64:1227-35. [PMID: 17364139 DOI: 10.1007/s00018-007-6533-0] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
10 Zhang S, Zeitzer JM, Sakurai T, Nishino S, Mignot E. Sleep/wake fragmentation disrupts metabolism in a mouse model of narcolepsy. J Physiol 2007;581:649-63. [PMID: 17379635 DOI: 10.1113/jphysiol.2007.129510] [Cited by in Crossref: 73] [Cited by in F6Publishing: 72] [Article Influence: 4.9] [Reference Citation Analysis]
11 Black SW, Schwartz MD, Chen TM, Hoener MC, Kilduff TS. Trace Amine-Associated Receptor 1 Agonists as Narcolepsy Therapeutics. Biol Psychiatry 2017;82:623-33. [PMID: 27919403 DOI: 10.1016/j.biopsych.2016.10.012] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 4.7] [Reference Citation Analysis]
12 Kublaoui BM, Gemelli T, Tolson KP, Wang Y, Zinn AR. Oxytocin deficiency mediates hyperphagic obesity of Sim1 haploinsufficient mice. Mol Endocrinol 2008;22:1723-34. [PMID: 18451093 DOI: 10.1210/me.2008-0067] [Cited by in Crossref: 154] [Cited by in F6Publishing: 165] [Article Influence: 11.0] [Reference Citation Analysis]
13 Adamantidis A, Carter MC, de Lecea L. Optogenetic deconstruction of sleep-wake circuitry in the brain. Front Mol Neurosci 2010;2:31. [PMID: 20126433 DOI: 10.3389/neuro.02.031.2009] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 2.6] [Reference Citation Analysis]
14 Verberne AJ, Mussa BM. Neural control of pancreatic peptide hormone secretion. Peptides 2022;152:170768. [DOI: 10.1016/j.peptides.2022.170768] [Reference Citation Analysis]
15 Black SW, Morairty SR, Fisher SP, Chen TM, Warrier DR, Kilduff TS. Almorexant promotes sleep and exacerbates cataplexy in a murine model of narcolepsy. Sleep 2013;36:325-36. [PMID: 23449602 DOI: 10.5665/sleep.2442] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Gotter AL, Garson SL, Stevens J, Munden RL, Fox SV, Tannenbaum PL, Yao L, Kuduk SD, McDonald T, Uslaner JM, Tye SJ, Coleman PJ, Winrow CJ, Renger JJ. Differential sleep-promoting effects of dual orexin receptor antagonists and GABAA receptor modulators. BMC Neurosci 2014;15:109. [PMID: 25242351 DOI: 10.1186/1471-2202-15-109] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 3.5] [Reference Citation Analysis]
17 Morton AJ, Wood NI, Hastings MH, Hurelbrink C, Barker RA, Maywood ES. Disintegration of the sleep-wake cycle and circadian timing in Huntington's disease. J Neurosci 2005;25:157-63. [PMID: 15634777 DOI: 10.1523/JNEUROSCI.3842-04.2005] [Cited by in Crossref: 263] [Cited by in F6Publishing: 134] [Article Influence: 15.5] [Reference Citation Analysis]
18 Elam HB, Perez SM, Donegan JJ, Lodge DJ. Orexin receptor antagonists reverse aberrant dopamine neuron activity and related behaviors in a rodent model of stress-induced psychosis. Transl Psychiatry 2021;11:114. [PMID: 33558469 DOI: 10.1038/s41398-021-01235-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Mohammed M, Yanagisawa M, Blessing W, Ootsuka Y. Attenuated cold defense responses in orexin neuron-ablated rats. Temperature (Austin) 2016;3:465-75. [PMID: 28349086 DOI: 10.1080/23328940.2016.1184366] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
20 Callander GE, Olorunda M, Monna D, Schuepbach E, Langenegger D, Betschart C, Hintermann S, Behnke D, Cotesta S, Fendt M, Laue G, Ofner S, Briard E, Gee CE, Jacobson LH, Hoyer D. Kinetic properties of "dual" orexin receptor antagonists at OX1R and OX2R orexin receptors. Front Neurosci 2013;7:230. [PMID: 24376396 DOI: 10.3389/fnins.2013.00230] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
21 Liu M, Thankachan S, Kaur S, Begum S, Blanco-Centurion C, Sakurai T, Yanagisawa M, Neve R, Shiromani PJ. Orexin (hypocretin) gene transfer diminishes narcoleptic sleep behavior in mice. Eur J Neurosci 2008;28:1382-93. [PMID: 18973565 DOI: 10.1111/j.1460-9568.2008.06446.x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 39] [Article Influence: 3.2] [Reference Citation Analysis]
22 Scammell TE, Saper CB. Orexins: looking forward to sleep, back at addiction. Nat Med 2007;13:126-8. [PMID: 17290266 DOI: 10.1038/nm0207-126] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.3] [Reference Citation Analysis]
23 Beuckmann CT, Ueno T, Nakagawa M, Suzuki M, Akasofu S. Preclinical in vivo characterization of lemborexant (E2006), a novel dual orexin receptor antagonist for sleep/wake regulation. Sleep 2019;42:zsz076. [PMID: 30923834 DOI: 10.1093/sleep/zsz076] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
24 Azzam S, Schlatzer D, Nethery D, Saleh D, Li X, Akladious A, Chance MR, Strohl KP. Proteomic profiling of the hypothalamus in two mouse models of narcolepsy. Proteomics 2017;17. [PMID: 28544614 DOI: 10.1002/pmic.201600478] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
25 Mavanji V, Teske JA, Billington CJ, Kotz CM. Elevated sleep quality and orexin receptor mRNA in obesity-resistant rats. Int J Obes (Lond) 2010;34:1576-88. [PMID: 20498657 DOI: 10.1038/ijo.2010.93] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 2.8] [Reference Citation Analysis]
26 Watson CJ, Baghdoyan HA, Lydic R. Neuropharmacology of Sleep and Wakefulness. Sleep Med Clin 2010;5:513-28. [PMID: 21278831 DOI: 10.1016/j.jsmc.2010.08.003] [Cited by in Crossref: 47] [Cited by in F6Publishing: 34] [Article Influence: 3.9] [Reference Citation Analysis]
27 Brown JA, Woodworth HL, Leinninger GM. To ingest or rest? Specialized roles of lateral hypothalamic area neurons in coordinating energy balance. Front Syst Neurosci 2015;9:9. [PMID: 25741247 DOI: 10.3389/fnsys.2015.00009] [Cited by in Crossref: 47] [Cited by in F6Publishing: 51] [Article Influence: 6.7] [Reference Citation Analysis]
28 Kantor S, Mochizuki T, Janisiewicz AM, Clark E, Nishino S, Scammell TE. Orexin neurons are necessary for the circadian control of REM sleep. Sleep 2009;32:1127-34. [PMID: 19750917 DOI: 10.1093/sleep/32.9.1127] [Cited by in Crossref: 65] [Cited by in F6Publishing: 58] [Article Influence: 5.0] [Reference Citation Analysis]
29 Winsky-Sommerer R, Boutrel B, de Lecea L. Stress and arousal: the corticotrophin-releasing factor/hypocretin circuitry. Mol Neurobiol 2005;32:285-94. [PMID: 16385142 DOI: 10.1385/MN:32:3:285] [Cited by in Crossref: 91] [Cited by in F6Publishing: 52] [Article Influence: 5.7] [Reference Citation Analysis]
30 Nixon JP, Mavanji V, Butterick TA, Billington CJ, Kotz CM, Teske JA. Sleep disorders, obesity, and aging: the role of orexin. Ageing Res Rev 2015;20:63-73. [PMID: 25462194 DOI: 10.1016/j.arr.2014.11.001] [Cited by in Crossref: 61] [Cited by in F6Publishing: 51] [Article Influence: 7.6] [Reference Citation Analysis]
31 Blanco-Centurion C, Gerashchenko D, Shiromani PJ. Effects of saporin-induced lesions of three arousal populations on daily levels of sleep and wake. J Neurosci 2007;27:14041-8. [PMID: 18094243 DOI: 10.1523/JNEUROSCI.3217-07.2007] [Cited by in Crossref: 90] [Cited by in F6Publishing: 61] [Article Influence: 6.4] [Reference Citation Analysis]
32 Wang C, Wang Q, Ji B, Pan Y, Xu C, Cheng B, Bai B, Chen J. The Orexin/Receptor System: Molecular Mechanism and Therapeutic Potential for Neurological Diseases. Front Mol Neurosci 2018;11:220. [PMID: 30002617 DOI: 10.3389/fnmol.2018.00220] [Cited by in Crossref: 55] [Cited by in F6Publishing: 53] [Article Influence: 13.8] [Reference Citation Analysis]
33 Watson CJ, Baghdoyan HA, Lydic R. Neuropharmacology of Sleep and Wakefulness: 2012 Update. Sleep Med Clin 2012;7:469-86. [PMID: 23162386 DOI: 10.1016/j.jsmc.2012.06.010] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
34 Smith RJ, See RE, Aston-Jones G. Orexin/hypocretin signaling at the orexin 1 receptor regulates cue-elicited cocaine-seeking. Eur J Neurosci 2009;30:493-503. [PMID: 19656173 DOI: 10.1111/j.1460-9568.2009.06844.x] [Cited by in Crossref: 157] [Cited by in F6Publishing: 151] [Article Influence: 12.1] [Reference Citation Analysis]
35 Teske JA, Mavanji V. Energy expenditure: role of orexin. Vitam Horm 2012;89:91-109. [PMID: 22640610 DOI: 10.1016/B978-0-12-394623-2.00006-8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
36 Murillo-Rodriguez E, Liu M, Blanco-Centurion C, Shiromani PJ. Effects of hypocretin (orexin) neuronal loss on sleep and extracellular adenosine levels in the rat basal forebrain. Eur J Neurosci 2008;28:1191-8. [PMID: 18783368 DOI: 10.1111/j.1460-9568.2008.06424.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
37 Tolson KP, Gemelli T, Gautron L, Elmquist JK, Zinn AR, Kublaoui BM. Postnatal Sim1 deficiency causes hyperphagic obesity and reduced Mc4r and oxytocin expression. J Neurosci 2010;30:3803-12. [PMID: 20220015 DOI: 10.1523/JNEUROSCI.5444-09.2010] [Cited by in Crossref: 88] [Cited by in F6Publishing: 67] [Article Influence: 7.3] [Reference Citation Analysis]
38 Jessberger S, Nakashima K, Clemenson GD Jr, Mejia E, Mathews E, Ure K, Ogawa S, Sinton CM, Gage FH, Hsieh J. Epigenetic modulation of seizure-induced neurogenesis and cognitive decline. J Neurosci 2007;27:5967-75. [PMID: 17537967 DOI: 10.1523/JNEUROSCI.0110-07.2007] [Cited by in Crossref: 239] [Cited by in F6Publishing: 109] [Article Influence: 15.9] [Reference Citation Analysis]
39 Chen L, Brown RE, McKenna JT, McCarley RW. Animal models of narcolepsy. CNS Neurol Disord Drug Targets 2009;8:296-308. [PMID: 19689311 DOI: 10.2174/187152709788921717] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
40 John J, Wu MF, Maidment NT, Lam HA, Boehmer LN, Patton M, Siegel JM. Developmental changes in CSF hypocretin-1 (orexin-A) levels in normal and genetically narcoleptic Doberman pinschers. J Physiol 2004;560:587-92. [PMID: 15308685 DOI: 10.1113/jphysiol.2004.070573] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
41 Kaur S, Thankachan S, Begum S, Blanco-Centurion C, Sakurai T, Yanagisawa M, Shiromani PJ. Entrainment of temperature and activity rhythms to restricted feeding in orexin knock out mice. Brain Res 2008;1205:47-54. [PMID: 18343358 DOI: 10.1016/j.brainres.2008.02.026] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 2.9] [Reference Citation Analysis]
42 Diniz Behn CG, Kopell N, Brown EN, Mochizuki T, Scammell TE. Delayed orexin signaling consolidates wakefulness and sleep: physiology and modeling. J Neurophysiol 2008;99:3090-103. [PMID: 18417630 DOI: 10.1152/jn.01243.2007] [Cited by in Crossref: 51] [Cited by in F6Publishing: 47] [Article Influence: 3.6] [Reference Citation Analysis]
43 Rempe MJ, Clegern WC, Wisor JP. An automated sleep-state classification algorithm for quantifying sleep timing and sleep-dependent dynamics of electroencephalographic and cerebral metabolic parameters. Nat Sci Sleep 2015;7:85-99. [PMID: 26366107 DOI: 10.2147/NSS.S84548] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
44 Chen L, Mckenna JT, Bolortuya Y, Winston S, Thakkar MM, Basheer R, Brown RE, Mccarley RW. Knockdown of orexin type 1 receptor in rat locus coeruleus increases REM sleep during the dark period: Orexin type 1 receptor knockdown increases REM. European Journal of Neuroscience 2010;32:1528-36. [DOI: 10.1111/j.1460-9568.2010.07401.x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 2.8] [Reference Citation Analysis]
45 Tortorella S, Rodrigo-Angulo ML, Núñez A, Garzón M. Synaptic interactions between perifornical lateral hypothalamic area, locus coeruleus nucleus and the oral pontine reticular nucleus are implicated in the stage succession during sleep-wakefulness cycle. Front Neurosci 2013;7:216. [PMID: 24311996 DOI: 10.3389/fnins.2013.00216] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
46 Matharu N, Rattanasopha S, Tamura S, Maliskova L, Wang Y, Bernard A, Hardin A, Eckalbar WL, Vaisse C, Ahituv N. CRISPR-mediated activation of a promoter or enhancer rescues obesity caused by haploinsufficiency. Science 2019;363:eaau0629. [PMID: 30545847 DOI: 10.1126/science.aau0629] [Cited by in Crossref: 112] [Cited by in F6Publishing: 98] [Article Influence: 28.0] [Reference Citation Analysis]
47 Olson CA, Hamilton NA, Somers VK. Percentage of REM sleep is associated with overnight change in leptin. J Sleep Res 2016;25:419-25. [PMID: 26919408 DOI: 10.1111/jsr.12394] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
48 Brevig HN, Watson CJ, Lydic R, Baghdoyan HA. Hypocretin and GABA interact in the pontine reticular formation to increase wakefulness. Sleep 2010;33:1285-93. [PMID: 21061850 DOI: 10.1093/sleep/33.10.1285] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
49 Rappas M, Ali AAE, Bennett KA, Brown JD, Bucknell SJ, Congreve M, Cooke RM, Cseke G, de Graaf C, Doré AS, Errey JC, Jazayeri A, Marshall FH, Mason JS, Mould R, Patel JC, Tehan BG, Weir M, Christopher JA. Comparison of Orexin 1 and Orexin 2 Ligand Binding Modes Using X-ray Crystallography and Computational Analysis. J Med Chem 2020;63:1528-43. [PMID: 31860301 DOI: 10.1021/acs.jmedchem.9b01787] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
50 Scammell TE, Winrow CJ. Orexin receptors: pharmacology and therapeutic opportunities. Annu Rev Pharmacol Toxicol 2011;51:243-66. [PMID: 21034217 DOI: 10.1146/annurev-pharmtox-010510-100528] [Cited by in Crossref: 202] [Cited by in F6Publishing: 194] [Article Influence: 18.4] [Reference Citation Analysis]
51 Kohlmeier KA, Tyler CJ, Kalogiannis M, Ishibashi M, Kristensen MP, Gumenchuk I, Chemelli RM, Kisanuki YY, Yanagisawa M, Leonard CS. Differential actions of orexin receptors in brainstem cholinergic and monoaminergic neurons revealed by receptor knockouts: implications for orexinergic signaling in arousal and narcolepsy. Front Neurosci 2013;7:246. [PMID: 24391530 DOI: 10.3389/fnins.2013.00246] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 3.8] [Reference Citation Analysis]
52 Korostovtseva L. Ischemic Stroke and Sleep: The Linking Genetic Factors. Cardiol Ther 2021. [PMID: 34191267 DOI: 10.1007/s40119-021-00231-9] [Reference Citation Analysis]
53 Black SW, Yamanaka A, Kilduff TS. Challenges in the development of therapeutics for narcolepsy. Prog Neurobiol 2017;152:89-113. [PMID: 26721620 DOI: 10.1016/j.pneurobio.2015.12.002] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 4.6] [Reference Citation Analysis]
54 Zhang S, Lin L, Kaur S, Thankachan S, Blanco-Centurion C, Yanagisawa M, Mignot E, Shiromani PJ. The development of hypocretin (orexin) deficiency in hypocretin/ataxin-3 transgenic rats. Neuroscience 2007;148:34-43. [PMID: 17618058 DOI: 10.1016/j.neuroscience.2007.05.029] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 2.1] [Reference Citation Analysis]
55 Chen L, Thakkar MM, Winston S, Bolortuya Y, Basheer R, McCarley RW. REM sleep changes in rats induced by siRNA-mediated orexin knockdown. Eur J Neurosci 2006;24:2039-48. [PMID: 17067300 DOI: 10.1111/j.1460-9568.2006.05058.x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 46] [Article Influence: 3.1] [Reference Citation Analysis]
56 Zhou L, Sun WL, See RE. Orexin Receptor Targets for Anti-Relapse Medication Development in Drug Addiction. Pharmaceuticals (Basel) 2011;4:804-21. [PMID: 23997653 DOI: 10.3390/ph4060804] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
57 De la Herrán-arita AK, Drucker-colín R. Models for narcolepsy with cataplexy drug discovery. Expert Opinion on Drug Discovery 2012;7:155-64. [DOI: 10.1517/17460441.2012.651454] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
58 Boutrel B, de Lecea L. Addiction and arousal: the hypocretin connection. Physiol Behav. 2008;93:947-951. [PMID: 18262574 DOI: 10.1016/j.physbeh.2007.11.022] [Cited by in Crossref: 63] [Cited by in F6Publishing: 65] [Article Influence: 4.2] [Reference Citation Analysis]
59 Wu MF, Nienhuis R, Maidment N, Lam HA, Siegel JM. Cerebrospinal fluid hypocretin (orexin) levels are elevated by play but are not raised by exercise and its associated heart rate, blood pressure, respiration or body temperature changes. Arch Ital Biol 2011;149:492-8. [PMID: 22205595 DOI: 10.4449/aib.v149i4.1315] [Cited by in F6Publishing: 11] [Reference Citation Analysis]
60 Black SW, Morairty SR, Fisher SP, Chen TM, Warrier DR, Kilduff TS. Almorexant promotes sleep and exacerbates cataplexy in a murine model of narcolepsy. Sleep 2013;36:325-36. [PMID: 23449602 DOI: 10.5665/sleep.2442] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 4.2] [Reference Citation Analysis]